In transformed cells, the E1A gene of adenovirus type 12 (Adl2) represses transcription of class I genes of the major histocompatibility complex. The tumorigenic potential ofAdl2-transformed cells correlates with this diminished class I expression. In contrast, the E1A gene of the nontumorigenic Ad5 does not affect class I expression. We show here that a transfected reporter chloramphenicol acetyltransferase plasmid driven by an H-2K promoter (-1049 bp) was expressed at much lower levels in Adl2-than in Ad5-transformed mouse cells.
expression. We show here that a transfected reporter chloramphenicol acetyltransferase plasmid driven by an H-2K promoter (-1049 bp) was expressed at much lower levels in Adl2-than in Ad5-transformed mouse cells.
Analysis of mutant constructs revealed that only 83 bp of H-2 DNA, consisting of the enhancer juxtaposed to the basal promoter, was sufficient for this differential expression. Whereas the H-2 basal promoter alone was somewhat less active in Adl2-transformed cells, the H-2 TATA box itself did not appear to be important. The H-2 enhancer proved to be the principal element in Adl2 ElA-mediated repression, since (i) substitution of the H-2 enhancer by simian virus 40 enhancers overcame the repression, and (ii) when juxtaposed to either its native or heterologous basal promoters, the H-2 enhancer was functional in AdS-but not Adl2-transformed cells. Mobility shift assays showed that there is a DNA-binding activity to the 5' site (R2 element) of the enhancer that is significantly higher in Adl2-than in Ad5-transformed cells. These results suggest that decreased class I enhancer activity in Adl2-transformed cells may, at least in part, be due to the higher levels of an enhancer-specific factor, possibly acting as a repressor.
All adenovirus serotypes can transform rodent cells in vitro, but only some are capable of generating tumors in rodents. This difference has been used to group adenoviruses as highly oncogenic, weakly oncogenic, or nononcogenic (15) . Expression of the major histocompatibility complex (MHC) class I genes is diminished in cells transformed by the highly oncogenic adenovirus type 12 (Adl2) but not by the nononcogenic Ad5 (13, 39) . Class I genes encode surface antigens (H-2K, H-2D, and H-2L in mice) that are expressed by most cells and play an important role in immune recognition (reviewed in references 11 and 44) . Since foreign and class I antigens must be corecognized by cytotoxic T lymphocytes for lysis of target cells to occur (53) , the reduced levels of class I antigens on Adl2-transformed cells may favor their escape from immunosurveillance and act as an important step in tumorigenesis (7, 13, 43, 52) .
In both human and mouse cells transformed by Adl2, the levels of each of the class I antigens and mRNAs are greatly reduced (13, 39, 47) . Nuclear run-on experiments demonstrated that the low class I mRNA levels result from a decrease in the rate of transcription (1, 16) . Reduced transcription is not due to structural perturbation of the class I genes, since they remain responsive to interferon stimulation (12, 13) . The Adl2 ElA gene, which encodes two overlapping proteins of 266 and 235 residues, is capable of repress-ing class I transcription in the absence of other adenovirus genes (47) .
ElA is multifunctional. It transforms primary cells in cooperation with other oncogenes such as the adenovirus E1B, polyomavirus middle T antigen, and ras genes (reviewed in references 8 and 37) ; for this process to occur, the binding of cellular proteins to ElA protein appears to be essential (51) . ElA also transactivates certain viral and cellular genes, likely by interacting with cellular transcription factors (6, 24, 32, 50) . In addition, ElA prevents some enhancers, e.g., the simian virus 40 (SV40) and immunoglobulin G enhancers, from stimulating transcription (9, 22, 48 cells and that its ability to repress transcription is dependent on factor binding.
MATERIALS AND METHODS
Cell lines. Cell lines transformed with Ad5 (Wt5a, KAd5-3, and BrAd5) and Adl2 (F10-12, EAd12-1, and 12A1) were derived from primary mouse BALB/c (H-2d) cells and have been described previously (13) .
Plasmid constructions. H-2 constructs were made in either plasmid pML or pBluescript. The parental H-2 promoter plasmid was constructed by subcloning the H-2K" fragment, PvuII-NruI (-1049 to + 12 relative to the transcription initiation site), upstream of the coding sequences of the reporter CAT gene (34, 49) . H-2 promoter deletion plasmids (pH2-364, pH2-118, and pH2-37) were constructed by cutting pH2-1049 with restriction enzymes XbaI, PpuMI, and SacII, respectively, and then subjecting the fragments to mung bean nuclease digestion and religation. For plasmids pH2-215, pH2-H2(E+IRS), pH2-H2E, and pH2-SVE, a polymerase chain reaction (PCR) was used to generate inserts with modified SacII ends, which were cloned into the SacII site of pH2-37. The inserts were -38 to -215, -123 to -215, and -159 to -205 of the H-2 promoter in pH2-215, pH2-H2(E+IRS), and pH2-H2E, respectively, and two copies of the SV40 72-bp enhancer (19) in pH2-SVE. pH2-H2(E+IRS)s is the same as pH2-H2(E+IRS) except for the second SacII site at position -215, which was destroyed by site-directed mutagenesis. pH2-s-H2(E+IRS) was made by inserting a PCR-amplified 80-bp fragment of pBR322 (bp 4210 to 4290) into the SacII site of pH2-H2(E+IRS)s. The sources of SV40 and herpes simplex virus type 1 thymidine kinase (TK) sequences were plasmids pSV2-CAT (19) and pHSV106 (33) , respectively. In pSV-H2(E+IRS) and pTK-H2(E+IRS), the H-2 enhancer is joined to the basal promoters of the early SV40 and herpes simplex type 1 TK genes, respectively. To construct pSV-H2(E+IRS), the SV40 early promoter of pSV2CAT was amplified by PCR from position -35 relative to the transcription start site (a SacII site was included in the oligonucleotide primer) to the NcoI site within the CAT coding region. The amplified DNA was used to replace the SacII-to-NcoI fragment of pH2-H2(E+IRS)s. To construct pTK-H2(E+IRS), the TK promoter from pTKCAT was amplified by PCR from position -40 (a SacII site was included in the primer) to the NcoI site within the CAT gene, and the amplified DNA was used to replace the SacII-to-NcoI fragment of pH2-H2 (E+IRS)s. Every construct was verified by DNA sequencing (38 
RESULTS

Expression of H-2 promoter plasmids is down-regulated in
Adl2-transformed cells. In Adl2-transformed cells, the diminished level of class I expression results from a block in transcription (1, 16) . To determine whether the promoters of the MHC class I genes are regulated by Adl2 EMA, plasmids containing a CAT reporter gene, driven by the class I H-2Kb promoter, were transfected into AdS-and Adl2-transformed mouse cell lines. The H-2 CAT plasmids (pH2-1049 and pH2-364) used in this experiment contained 1,049-and 364-bp sequences upstream of the transcriptional start site of the H-2K-promoter, respectively, and included known transcriptional regulatory elements (11, 28, 29, 35, 49) (Fig.  1 ). CAT activity from both plasmids was much lower in Adl2-than in Ad5-transformed cells (Fig. 2 ). In contrast, both AdS-and Adl2-transformed cells expressed nearly equivalent levels of CAT activity when transfected with pSV2CAT, in which the SV40 early promoter drives the CAT gene (Fig. 2) . These results reflect the disparity in transcription of endogenous class I genes between AdS-and Adl2-transformed cells and indicate that there is not a general difference in the ability of these cells to express exogenous genes. Furthermore, they demonstrate that sequences contained within 364 bp upstream of the H-2 promoter transcription start site are sufficient for down-regulation by Adl2 ElA. Consistent with these results was the low activity obtained in Adl2-but not AdS-transformed cells with use of the human class I HLA-A2 promoter (data not shown).
Promoter deletion suggests elements involved in repression. To locate sequences within the H-2 promoter which might be down-regulated by Adl2 EMA, a series of 5' deletions was constructed from the parental H-2 CAT plasmid, pH2-1049 (Fig. 3) . If Adl2-specific negative transcription elements reside in the upstream regulatory region of the class I gene, their removal is expected to result in equivalent CAT activity in AdS-and Adl2-transformed cells. However, the levels of CAT activity remained consistently low when each H-2 promoter deletion construct was transfected into Adl2-transformed cells (Fig. 3) . In contrast, a gradual decrease in promoter activity in AdS-transformed cells accompanied the deletion of regulatory elements (constructs pH2-118 and pH2-37). In both transformed cells, the level of CAT activity obtained with pH2-364 or pH2-215 was always higher (about 1.5 to 2 times) than that of the longest construct, pH2-1049, Ad suggesting the presence of a negative (cis-regulatory) element in the H-2 promoter that is not related to ElA repression.
The basal promoter could be a target for Ad12 E1A-mediated repression, since the level of CAT activity of construct pH2-37 was invariably higher (four-to fivefold) in Ad5-transformed cells (Fig. 3) . The fold difference in CAT activity between Ad5-and Adl2-transformed cells is the same as that obtained with the pH2-118 and pH2-37 constructs, suggesting that sequences between -37 and -118 are not involved in the repression. A comparison of the pH2-215 and pH2-118 constructs indicates the potential involvement of the enhancer-interferon regulatory sequence (IRS) elements, since they stimulate CAT activity in AdSbut not in Adl2-transformed cells.
To address whether the basal promoter and the enhancer are the only elements that play a role in Ad12 ElA-mediated repression, we deleted sequences between these elements (-118 to -38) to generate pH2-H2(E+IRS) (Fig. 4) . Full differential expression was retained when pH2-H2(E+IRS) was transfected into Ad5-and Adl2-transformed cells (Fig.  4) . Moreover, when the normal H-2 sequences between the enhancer-IRS and TATA regions were replaced with a random plasmid sequence of identical length, a major difference in CAT activity between AdS-and Adl2-transformed cells was still observed [pH2-s-H2(E+IRS); Fig. 4 ].
These studies demonstrate that only 130 bp, which include the enhancer-IRS and basal promoter elements, are sufficient to recapitulate the negative effect of Adl2 ElA. Deletion of sequences upstream of the enhancer (-1049 to -215), as well as those between the enhancer-IRS and basal promoter (-118 to -38), had no effect on the differential class I expression between the Ad5-and Adl2-transformed cells.
Alteration of the TATA box of the H-2 basal promoter does not restore class I transcription in Adl2-transformed cells. The H-2 TATA element has a sequence that is known to be responsive to ElA transactivation (42) . When the H-2 TATA sequence (TATAAAGT) was converted by site-directed mutagenesis into an SV40 TATA sequence (TATTTATT) known to be nonresponsive to ElA transactivation (42) or to an SV40-like TATA sequence (TAT'l'AGT) and placed into the background of pH2-364 or pH2-37, the CAT activity in either AdS-or Adl2-transformed cells was not changed (data not shown). These results imply that the differential expression of the H-2 basal promoter does not result from the H-2 TATA box sequence being repressed by Adl2 ElA or activated by AdS ElA. Although the TATA box is the only apparent regulatory element in the -37 region, we cannot rule out an effect due to other sequences.
The H-2 enhancer fails to function in Adl2-transformed cells. From the deletion analysis ( Fig. 3 and 4) , the shortest sequence of the H-2 promoter sufficient for retaining full differential expression in AdS-and Adl2-transformed cells was a 130-bp fragment containing the enhancer-IRS region joined to the basal promoter. To evaluate the contribution of the enhancer alone in repression, we tested pH2-H2E, in which the 46-bp H-2 enhancer was placed directly upstream of the 37-bp basal promoter (Fig. 4) . pH2-H2E was still expressed at much lower levels in Adl2-transformed cells [compare pH2-H2(E+IRS) with pH2-H2E; Fig. 4 ]. Thus, the IRS sequence is not essential for Adl2 ElA-mediated repression. Most importantly, the H-2 enhancer fails to stimulate transcription from its basal promoter in Adl2-transformed cells but does so efficiently in AdS-transformed cells. When the SV40 72-bp enhancer repeats were juxtaposed to the H-2 basal promoter (pH2-SVE), CAT activity was ex- pressed at very high levels in both Ad5-and Adl2-transformed cells (Fig. 4) . Furthermore, a monomer or a dimer of an SP1 binding site activated H-2 promoter transcription with comparable efficiency in Ad5-and Adl2-transformed cells (not shown). Therefore, the basal promoter is capable of being stimulated in Adl2-transformed cells. Still, in the context of its own enhancer, the H-2 basal promoter may contribute to the low levels of class I transcription in these cells.
To determine how the class I enhancer functions in the context of heterologous basal promoters, a fragment containing the H-2 enhancer was linked to the early SV40 or herpes simplex virus type 1 TK basal promoter [pSV-H2(E+IRS) or pTK-H2(E+IRS), respectively; Fig. 5 ]. In Ad5-transformed cells, the enhancer stimulated CAT activity four-to fivefold relative to the SV40 and TK basal promoters, while in Adl2-transformed cells, the H-2 enhancer had no stimulatory effect. Thus, in the Adl2-transformed cells, the class I enhancer is incapable of functioning as a transcription element.
In summary, these results demonstrate that the H-2 enhancer is a principal element in Adl2 ElA-mediated repression. When juxtaposed either to its native basal promoter or to heterologous basal promoters, the H-2 enhancer stimulates transcription in Ad5-but not Adl2-transformed cells. Maximum differential expression of class I genes between AdS-and Adl2-transformed cells requires the H-2 enhancer. The H-2 basal promoter is not sufficient to confer repression when linked to a heterologous enhancer, e.g., the SV40 enhancer, or to an upstream activator sequence such as the SP1 site.
Increased factor binding to the H-2 enhancer in Adl2-versus AdS-transformed cells. Differential regulation of class I transcription in adenovirus-transformed cells could be due to the absence of a positive factor or the presence of a negative factor that binds to the H-2 promoter. First, we compared AdS-and Adl2-transformed cells for differences in binding activity throughout the 5' regulatory region of the class I promoter. Extracts were prepared from two AdS-and three Adl2-transformed cell lines and analyzed for their DNA-binding activities by mobility shift assays, using DNA fragments that scanned the promoter from -474 to +12. A major difference was detected with a fragment (-215 to -122) that included the enhancer and the IRS. Extracts from Adl2-transformed cells showed a higher binding activity to this fragment. Separation of the enhancer and the IRS at -165 indicated that this differential binding was to the enhancer and not to the IRS (data not shown).
Mobility shift assays with an oligonucleotide (H2E) that represents the complete H-2 enhancer (-205 to -156) confirmed that Adl2-transformed cell extracts contain higher levels of an enhancer-binding activity designated complex A (Fig. 6) . We emphasize that the sequences contained within the enhancer oligonucleotide accounted for all of the differential binding found with the larger fragments. By comparison, several other DNA-protein complexes were observed at similar levels in extracts from both cell types with the exception of a minor low-mobility complex that was at slightly higher levels in Adl2-transformed cells. All of the complexes were specific, since their formation was inhibited by an excess of unlabeled H-2 enhancer oligonucleotide (Fig.  6b, lanes 2 and 9) but not by an unrelated oligonucleotide (lanes 7 and 14) .
Since the H-2 enhancer contains at least two known factor-binding sites (Ri and R2; Fig. 1) , it was important to determine which of them was responsible for complex A. Therefore, we analyzed binding in the presence of excess cold oligonucleotides that contained site Ri (-176 to -156) or site R2 (-205 to -184). Complex A formation was effectively inhibited by the R2 oligonucleotide (Fig. 6b, lanes   4 and 11) but not by the Ri oligonucleotide (lanes 3 and 10), suggesting that its binding depends on the R2 site. Formation of all enhancer-binding complexes was inhibited by a combination of oligonucleotides Ri and R2 (Fig. 6b, lanes5 and   12 ). This finding suggested that no other H-2 enhancer sequences were recognized by these nuclear extracts. Thus, Adl2-transformed cells have significantly higher levels of a DNA-binding activity to the R2 site of the H-2 enhancer, represented by complex A, than do Ad5-transformed cells.
Mobility shift assays with oligonucleotide R2 confirmed the increased DNA-binding activity to the R2 site ( Fig. 7; compare lanes 2 and 6 with lanes 10, 14, and 18). R2, which contains a putative CREB site, has been reported to be recognized by AP-1 (29) and by H-2RIIBP (21) . Formation of complex A was inhibited by an oligonucleotide excess that contained the CREB site of the fibronectin gene (Fig. 7,   lanes 4, 8, 12, 16, and 20) . Similarly, competition with CREB sites of the somatostatin gene or of the CREB-related ATF site of the adenovirus E3 promoter failed to inhibit complex A formation indicating that this activity is distinct from CREB. Moreover, an oligonucleotide that contained an AP-1 site failed to compete (data not shown). As expected, the Rl oligonucleotide did not inhibit complex A formation (Fig. 7,   lanes 5, 9, 13, 17, and 21 ).
Binding assays with other regions of the H-2 promoter indicated no major differences in DNA-binding activities of nuclear extracts from Ad5-and Adl2-transformed cells (not shown). We also tested binding to a DNA recognition site, SPi, which is not present in the pH2-1049 promoter construct. As shown in Fig. 8 , all Ad5 and Adl2 nuclear extracts exhibited similar levels of SP1 binding, suggesting that the difference observed with the H-2 enhancer is specific and does not reflect a general difference in binding activity between the two types of transformed cells.
DISCUSSION
The ElA gene of Adl2 is known to repress class I transcription in transformed cells (1, 16) . We show here that this phenomenon is also observed with exogenous class I promoters. Specifically, the class I H-2K" promoter driving the reporter CAT gene is expressed at reduced levels in Adl2-but not in AdS-transformed cells. Significantly, a construct containing just the basal promoter (-37 to +12) and the enhancer (-205 to -159) retained the same differential expression between AdS-and Adl2-transformed cells as was observed with the full-length pH2-1049 promoter construct. The importance of the H-2 enhancer in Adl2 ElA-mediated repression was demonstrated by showing that it can stimulate transcription of heterologous basal promoters in AdS-but not in Adl2-transformed cells. Thus, the H-2 enhancer alone is sufficient for down-regulation of transcription in Adl2-transformed cells. In correlation with the genetic analysis, we find a higher binding activity to the R2 site of the enhancer (-205 to -185) with nuclear extracts from Adl2-compared with AdS-transformed cells, suggesting the presence of an R2-binding repressor in Adl2-transformed cells. This binding activity (referred to as complex A) recognizes the same site for the recently described factor H-2RIIBP, a member of the steroid hormone receptor superfamily (21) . The levels of H-2RIIBP mRNA are the same in Ad5-and Adl2-transformed cells (unpublished data), indicating either that the protein levels or binding activity of H-2RIIBP may differ in the two cell types or that other distinct factors are involved. Indeed, tissue-specific and developmental differences in factor binding to the R2 site (and the Rl site) have been observed (10).
In the class I enhancer there is an AP-1/CREB consensus binding site that overlaps with the H-2RIIBP binding site (28, 29) . Recently, both Ad5 and Adl2 ElA were shown to be capable of mediating repression of the collagenase promoter through an AP-1 complex binding site (17, 36, 46) . Notably, the surrounding DNA context of the AP-1 binding site appears to be influential, since an AP-1 site of the c-jun promoter is activated by both Ad5 and Adl2 ElA (46) . Our data suggest that class I repression by Adl2 ElA is not through an AP-1 complex, since an AP-1 oligonucleotide could not compete for R2-binding factors. In accord with our J. VIROL. 6 Al.-..
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-. observations, Ackrill and Blair (2) showed that in Adl2-but not Ad5-transformed rat cells, there was a binding activity to the 5' region of the class I enhancer which was distinct from AP-1, CREB, and ATF.
Interestingly, N-myc expressed in neuroblastoma cells was shown to repress class I transcription by reducing factor binding to the Ri enhancer site (31) . The Rl-binding factors are also greatly reduced in AKR tumor cells, in which class I mRNA levels are low (23) . Using the Ri site probe in mobility gel shift assays, we observed a slowly migrating complex present at slightly higher levels in extracts of Ad5-compared with Adl2-transformed cells (data not shown).
Ad5
Thus, while the role of the Ri site in negative regulation by Adl2 ElA cannot be excluded, functional studies, described in the accompanying report (30) ing it to other TATA box sequences failed to restore H-2 transcription in Adl2-transformed cells. Significantly, the SV40 enhancer stimulated the H-2 basal promoter activity to similarly high levels in both AdS-and Adl2-transformed cells, as did insertion of SP1 binding sites upstream of the H-2 basal promoter. These results suggest that an element other than the TATA box may be responsible for the low basal promoter activity in the Adl2-transformed cells and that its effect can be overcome by a strong heterologous enhancer.
In our experiments, the possibility that the transfected H-2 promoter is not down-regulated by Adl2 ElA but rather is transactivated by Ad5 ElA is unlikely for the following reasons. (i) In transformed mouse, human, and rat cells expressing Adl2 EMA, the levels of class I antigens and their mRNAs were lower than in the parental cells, control cell lines, and AdS-transformed cells (13, 18, 47) . In these studies, class I expression in the AdS-transformed cells was not higher than in parental or control cell lines (13, 18) . (ii) An Ad5 ElA plasmid had no apparent effect on the transcriptional activity of an H-2 CAT plasmid (pH2-364) cotransfected into HeLa or Adl2-transformed cells (17a). (iii) Somatic fusions generated from AdS-and Adl2-transformed cells displayed class I antigen levels as low as those in the Adl2-transformed parental cells (17a) .
It remains to be determined whether the mechanism by which Adl2 ElA represses transcriptional stimulation by the class I enhancer is related to how Ad5 ElA represses the SV40, polyomavirus, and immunoglobulin heavy-chain enhancers in infected or transfected cells (9, 22, 48) . In vivo competition with excess enhancer fragments was able to relieve AdS ElA repression of enhancer-containing reporter plasmids, suggesting that a negative effect is mediated through ElA alone or in combination with a negative cellular factor (9) . It is important to note that the SV40 enhancer constructs used in this study were expressed at similar levels in all adenovirus-transformed cell lines, suggesting that if any ElA-mediated repression did occur, it was to the same extent in both AdS-and Adl2-transformed cells.
In accord with our results, Kimura et al. (28) also showed that a transfected H-2 CAT plasmid was down-regulated in Adl2-but not in AdS-transformed mouse cells. However, they suggested that the class I enhancer is not the sole target of Adl2 ElA-mediated repression, since a CAT construct containing the class I enhancer linked to the conalbumin promoter was not extensively down-regulated in Adl2-transformed cells. Their inability to detect a substantial reduction in CAT activity could be related to the nature of the particular heterologous enhancer promoter construct that was used (28) . By comparison, we achieved greatly diminished activity in Ad12-transformed cells with CAT plasmids containing the class I enhancer linked either to its homologous promoter or to two different heterologous promoters.
There are conflicting results of studies using established (nonprimary) cells to analyze Ad12 ElA-mediated repression. Katoh et al. (27) suggested that in established 3Y1 cells, an element upstream of the class I enhancer (-1836 to -1521) is a target for repression, and that the enhancer is actually stimulated by ElA. In contrast, Vaessen et al. (45) failed to see any difference in class I expression following transfection of AdS or Ad12 ElA into 3Y1 cells. Similarly, we have never been able to produce any difference in class I synthesis in established cell lines in which we introduced ElA of Ad5 or Adl2 (18) .
Our study clearly shows that the class I enhancer is involved in Ad12 ElA-mediated repression in transformed mouse cells. This repression correlates with an increase in factor binding to the R2 element of the class I enhancer. Since transcriptional regulation of class I genes is potentially controlled by the binding of both positive and negative regulatory factors, the increased binding of a negative factor in Ad12-transformed cells could result in decreased transcription. Indeed, in the accompanying report (30) , we show that the R2 element can repress Ri-dependent transcription from the class I promoter in Ad12-transformed cells.
